Hplc-validation of moxifloxacin
Abstract
The structure formula of moxifloxacin is described as follows: 8 methoxy flouroquinolone: and it is broad spectrum antibiotic [1, 2].we study moxifloxacin by IV drug delivery system. And for its study following apparatus is used; 1-a reversed-phase Lichrospher RP-18 column, 2-a mobile phase which is composed of different solvents. It is detected at a wavelength of 290 nm. By this method the retention time of moxifloxacin is very short. When we detect it in plasma and brain tissue linear curves are obtained. .The advantage of this method is that we can detect the bacteria in plasma and brain tissues by this method.
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.